Recon: Vaccine makers shift sights to boosters; Europe launches SPAC aimed at acquiring CDMOs
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy